checkAd
    Startseite > Aktien > Phaxiam Therapeutics > Nachrichten
    Phaxiam Therapeutics Aktie
    2,9975
     
    EUR
    +0,25 %
    +0,0075 EUR
    Letzter Kurs 17:18:46 Lang & Schwarz
    2,9950
     
    EUR
    339 STK
    Geldkurs 17:18:46
    3,0000
     
    EUR
    339 STK
    Briefkurs 17:18:46
    ISIN: FR001400K4B1 · WKN: A3EJH8 · Frankreich

    Neueste Nachrichten

    PHAXIAM provides Business and Financial Update for the First Quarter of 2024
    15.05.24 · globenewswire · Phaxiam Therapeutics
    Monthly information related to total number of voting rights and shares composing the share capital – April 30, 2024
    03.05.24 · globenewswire · Phaxiam Therapeutics
    PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus
    15.04.24 · globenewswire · Phaxiam Therapeutics
    Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024
    09.04.24 · globenewswire · Phaxiam Therapeutics
    PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)
    05.04.24 · globenewswire · Phaxiam Therapeutics
    PHAXIAM Announces 2023 Full-Year Results and Provides Business Update
    20.03.24 · globenewswire · Phaxiam Therapeutics
    PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
    11.03.24 · globenewswire · Phaxiam Therapeutics
    Monthly information related to total number of voting rights and shares composing the share capital - February 29, 2024
    05.03.24 · globenewswire · Phaxiam Therapeutics
    PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market
    20.02.24 · globenewswire · Phaxiam Therapeutics
    Monthly information related to total number of voting rights and shares composing the share capital - January 31, 2024
    06.02.24 · globenewswire · Phaxiam Therapeutics
    PHAXIAM Therapeutics announces its cash position at the end of 2023 and its financial calendar for 2024
    18.01.24 · globenewswire · Phaxiam Therapeutics
    Monthly information related to total number of voting rights and shares composing the share capital - December 31, 2023
    03.01.24 · globenewswire · Phaxiam Therapeutics